NextLOGiK will launch a new Qeb-based cost analysis tool for laboratories at its Symposium for Clinical Laboratories, May 15-18 in San Diego.
The new tool, called LabClarity, is designed to help physician offices and hospital laboratories perform cost/benefit analyses on a wide array of lab tests. The tool enables lab managers to evaluate differing scenarios such as procedure methodologies, personnel utilization, and reimbursement fees, to better understand the cost effects of testing, thereby improving operational efficiency.
The new tool is available to all laboratories, including non-COLA clients. For more information, visit www.labclarity.com or www.COLA.org.
